Affimed joins the Molecular Imaging Technology Initiative
BMBF awards Affimed a funding grant of €550K
Affimed Therapeutics AG announced the start of a collaboration project with Bayer Schering Pharma AG, the German Cancer Research Center (DKFZ) and other partners within the molecular imaging Technology Initiative launched by the German Federal Ministry of education and Research (“BMBF”). Affimed will receive a funded grant totaling more than €550.000 to carry out its part of the project.
BMBF supports the Molecular Imaging Technology Initiative for the development of new diagnostic methods and imaging technologies for clinical use and pharmaceutical applications.
Within this collaboration, Affimed will identify and isolate new molecules binding to membrane-associated targets on tumour tissues, using its highly diverse human antibody libraries. The optimised binding molecules in their final format will be further characterized in vitro by the other above mentioned collaboration partners. The main goal is to find new diagnostic tracer molecules for use in imaging technologies, but identified molecules could also be used for in vitro diagnostic purposes or the development of new pharmaceutical therapeutics.
Most read news
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Neutrons for better vaccines against multidrug resistant germs - FRM II lets scientists look deep inside the structure of biomolecules
Inflammatory biomarkers improve the clinical prediction of mortality in COPD
Germ-killing sanitizers could have effect on alcohol tests
Corcept Therapeutics and Xceleron sign agreement for microdosing study using accelerator mass spectrometry
Stretched, ordered DNA molecules could bring insights into disease
New, portable tech sniffs out plant disease in the field
Terahertz flashes uncover state of matter hidden by superconductivity
Pivoting hooks of graphene's chemical cousin could revolutionize work of electron microscopes
Troubling levels of toxic metals found in lipstick
MIT gel changes color on demand - Material could lead to fast, inexpensive sensors
LGC Standards continues its growth in emerging markets with first Russian office